Travere Therapeutics, Inc. TVTX FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s FX effect on cash?
- Travere Therapeutics, Inc. (TVTX) reported FX effect on cash of -$60K in Q1 2026.
- How has Travere Therapeutics, Inc.'s FX effect on cash changed year-over-year?
- Travere Therapeutics, Inc.'s FX effect on cash decreased by 110.9% year-over-year, from $548K to -$60K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.